Statistics about Health, Pharma & Medtech in Japan
Statistics
- Chugai pharmaceutical's sales share 2022, by disease area
- Takeda Pharmaceutical's revenue in the U.S. FY 2018-2022
- Takeda Pharmaceutical's revenue in Japan FY 2018-2022
- Takeda Pharmaceutical's R&D expenses FY 2018-2022
- Takeda Pharmaceutical's net profit FY 2018-2022
- Production volume of blood derivatives Japan 2016, by agent
- Fuji Pharma's net sales FY 2013-2022
- Medical and nursing related digital health market size Japan 2017-2024
- Paramount Bed Holdings' net sales FY 2022, by product
- Takeda Pharmaceutical's operating profit FY 2018-2022
- Takeda Pharmaceutical's gross profit FY 2018-2022
- Otsuka Holdings' female managers ratio 2014-2020
- Number of approved generic medical devices Japan FY 2013-2022, by year of submiss
- Number of medical drug manufacturing plants Japan 2018, by employee size
- Otsuka Holdings' total employees FY 2013-2022
- Device lag of new medical devices Japan FY 2011-2020
- Otsuka Holdings' factories number 2018, by location
- Astellas Pharma's R&D expenditure FY 2013-2022
- Sysmex's sales share 2022, by business
- Takeda Pharmaceutical's net income FY 2013-2022
- Chugai Pharmaceutical's operating profit FY 2013-2022
- Production value medical devices Japan 2018, by sub-therapeutic category
- Nichi-Iko's sales share of generics in Japan FY 2013-2022
- Annual growth of the hospital devices and equipment market in Japan FY 2011-2020
- Daiichi Sankyo's revenue FY 2013-2022
- Net sales of leading generics makers Japan 2020
- Sysmex's total assets FY 2011-2020
- Chugai Pharmaceutical's revenue 2013-2022
- Otsuka Holdings' total assets FY 2013-2022
- Opinion on possibility of doctors using AI for medical decisions Japan 2019
- Olympus Corporation's revenue share FY 2023, by region
- PACS and related devices market size Japan FY 2019-2025
- Forecast of economic impacts of FemTech market Japan 2025, by category
- Takeda Pharmaceutical's immunoglobulin sales value FY 2018-2022
- Takeda Pharmaceutical's ENTYVIO sales value FY 2018-2022
- Takeda Pharmaceutical's key products' sales values FY 2022
- Number of medical device patent applications Japan 2008-2017
- Astellas Pharma's female manager rate FY 2014-2017
- Takeda Pharmaceutical's revenue breakdown FY 2022, by region
- Takeda Pharmaceutical's revenue in Latin America FY 2018-2022
- Daiichi Sankyo's total employees FY 2013-2022
- Otsuka Holdings' R&D ratio to revenue FY 2013-2022
- Value of exported pharmaceutical drugs from Japan 2022, by region
- Most common reasons to not use FemTech products among women Japan 2023
- Leading pharmaceutical companies Japan 2023, by R&D costs
- Nichi-Iko's gross profit FY 2013-2022
- Awareness level of the word "FemTech" among women Japan 2023
- Major biopharma companies Japan FY 2022, by sales
- Intention of women to use FemTech products Japan 2023
- Share of women who have used FemTech services or products Japan 2023, by age
- Most commonly demanded FemTech cycle-related products and services Japan 2023
- Main FemTech and cycle-related problems among women Japan 2023
- Main problems among women relevant to FemTech Japan 2023
- Most commonly demanded FemTech products and services among women Japan 2023
- Number of medical device manufacturers Japan 2022, by production value
- Production volume antidiarrheals intestinal regulators Japan 2021, by agent
- Production value of period products Japan 2013-2022
- Number of medical drug manufacturing plants Japan 2022, by production value
- Nipro's net sales FY 2014-2023
- R&D expenditure of leading pharmaceutical manufacturers Japan FY 2021
- Breakdown of quasi-drugs production in Japan 2022, by therapeutic category
- Quasi drugs production value in Japan 2022, by therapeutic category
- Quasi drugs production value in Japan 2013-2022
- Japanese pharmaceutical companies top acquisitions as of 2014
- Daiichi Sankyo's total assets FY 2012-2021
- Paramount Bed Holdings' share of net sales FY 2021, by product
- Terumo's number of employees FY 2012-2021
- Breakdown value imported drugs Japan 2021, by category
- Major pharmaceutical companies in prescription drug sales Japan 2022, by distributor
- Prescription drug market sales share of LLPs Japan 2008-2019
- Companies with the highest number of pharmaceutical patent applications Japan 2022
- Prescription drug market size Japan 2003-2022
- Nipro's pharma packaging-related net sales FY 2014-2023
- Share of women using FemTech services Japan 2022
- Hair remedies production quantity in Japan 2016, by item
- Takeda Pharmaceutical's R&D expenditure FY 2013-2022
- Hospital devices and equipment market size Japan FY 2011-2019
- Daiichi Sankyo's net income FY 2013-2022
- Astellas Pharma's revenue FY 2022, by region
- Takeda Pharmaceutical's sales revenue of products FY 2022
- Nipro's sales share FY 2023, by business
- Sawai Group's sales revenue FY 2013-2022
- Towa Pharmaceutical's sales revenue FY 2012-2017
- Nichi-Iko's total assets FY 2013-2022
- Medicated cosmetics production value in Japan 2016, by items
- Otsuka Holdings' R&D spending FY 2013-2022
- Towa Pharmaceutical's employee numbers FY 2012-2017
- Production value of antidiarrheals intestinal regulators Japan 2021, by agent
- Value of exported pharmaceutical drugs from Japan 2021, by geographic region
- Fuji Pharma's R&D costs FY 2013-2022
- Value medical device exports from Japan 2021, by region
- Fuji Pharma's sales distribution FY 2022, by therapeutic category
- Hair remedies production amount in Japan 2021, by item
- Value of medical device exports from Japan 2013-2022
- Sysmex's R&D expenses FY 2013-2022
- Paramount Bed Holdings' total assets FY 2015-2022
- Otsuka Holdings' net income FY 2013-2022
- R&D spending of pharmaceutical companies Japan FY 2015-2022
- R&D spending of pharmaceutical companies in relation to sales Japan FY 2015-2022
- Paramount Bed Holdings' operating income FY 2015-2022